# Amantadine

## Dopadine100mg

| TAH Drug Code      | [ODOP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODOP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Parkinson's disease， prevention and treatment of influenza A symptoms.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Dosing             | Parkinson's disease: Adult: Monotherapy， 100 mg orally twice daily; may titrate up to 400 mg/day in divided doses. During a serious related disease or receiving high-dose anti-Parkinson's disease treatment， the initial dose of this agent is 100 mg once a day， After 1-7 weeks， if necessary， may titrate up to 100 mg twice a day; and additionally up to 400 mg/day in divided doses. Initiating levodopa and amantadine concurrently， hold amantadine at 100 mg once or twice daily while gradually increasing levodopa. Prophylaxis or treatment of Influenza A symptoms: (Due to high resistance rates， amantadine is no longer recommended by the CDC for the treatment or prophylaxis of influenza A.) Adult: 100-200mg/day. Children > 10 years old or > 45 kg: 100mg BID. Children > 5 years old: 100mg QD. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Contraindications  | ESRD (CrCl less than 15 mL/min/1.73 m(2)). Hypersensitivity to amantadine hydrochloride or to other components of the product. Pregnancy & lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Adverse Effects    | Common: Orthostatic hypotension (1-5% ; 13% (extended-release))， Peripheral edema (1-5% ; 16% (extended-release))， Constipation (1-5% ; 13% (extended-release))， Loss of appetite (1-6%)， Nausea (5-10%)， Xerostomia (1-5% ; 16% (extended-release))， Abnormal gait (3%)， Dizziness (5-10% ; 16% (extended-release))， Insomnia (5-10%)， Agitation (1-5%)， Anxiety (1-7%)， Depression (1-6% .)， Dream disorder (1-5%)， Feeling nervous (1-5%)， Hallucinations (1-5% .; 21% (extended-release))， Urinary tract infectious disease (10%)， Falls (13%) Serious: Congestive heart failure (0.1-1%)， Leukopenia (<0.1%)， Neutropenia (<0.1%)， Neuroleptic malignant syndrome， Suicidal intent (<0.1% ; 2% (extended-release))                                                                                      |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| More Info          | [UpToDate](https://www.uptodate.com/contents/amantadine-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

